In 2024, Croatia leads in per capita analgesic medicine sales at $77.6, followed by Norway at $42.6 and Germany at $33.5. Sweden, Belgium, and Canada show moderate values ranging from $20.8 to $26.1. Spain, Finland, and Slovenia present lower per capita sales, while Ireland, Austria, and the Baltic nations like Estonia and Latvia also report significant values around $10. Costa Rica and Hungary lag behind with minimal per capita expenditures on analgesics.
Year-on-year growth for 2023 highlights notable variations: Croatia (5.85%), Norway (4.74%), and Germany (5.28%) show strong upward trends. Estonia and Latvia exhibit the highest growth rates at 7.12% and 13.56%, respectively. Conversely, Ireland (-2.57%) and Hungary (-7.79%) face declines. Sweden and Belgium experience minimal variations, indicating stable markets.
Looking ahead, anticipate fluctuations driven by demographic shifts, healthcare policy changes, and innovations in pain management. Emerging markets and mature economies will show varying growth patterns, requiring adaptive strategies from market participants.
Top countries in Analgesic Medicine Sales by Country
| # | 10 Countries | US Dollars Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Croatia | 77.6 | 2023 | +3.88% | +5.85% | View data |
| 2 | 2 Norway | 42.6 | 2023 | +0.47% | +4.74% | View data |
| 3 | 3 Germany | 33.5 | 2023 | +2.45% | +5.28% | View data |
| 4 | 4 Sweden | 26.1 | 2023 | +1.16% | +0.15% | View data |
| 5 | 5 Belgium | 26 | 2023 | 0% | +0.87% | View data |
| 6 | 6 Canada | 20.8 | 2023 | -1.42% | +0.096% | View data |
| 7 | 7 Spain | 19.8 | 2023 | +4.21% | +0.93% | View data |
| 8 | 8 Finland | 17.7 | 2023 | +1.14% | +5.26% | View data |
| 9 | 9 Slovenia | 12.4 | 2023 | 0% | +3.58% | View data |
| 10 | 10 Ireland | 11.5 | 2023 | -2.54% | -2.57% | View data |
